It is also of interest that ZEB1 induces an increase in the expression of both LOXL4 (25) and annexin A2 (27) in breast cancer cells, and ZEB1 thus has the potential to naturally enhance the mechanism of LOXL4 in TNBCs upon S100A8/A9 stimulation. Here, S100A8 is linked to breast carcinoma.